DSGN Design Therapeutics, Inc.

13d ago, source: Seeking Alpha

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Independent Director of Design Therapeutics Picks Up 88% More Stock

29d ago, source: Yahoo Finance

Whilst it may not be a huge deal, we thought it was good to see that the Design Therapeutics, Inc. (NASDAQ:DSGN) Independent Director, John Schmid, recently bought US$100k worth of stock ...

Design Therapeutics (NASDAQ: DSGN)

27d ago, source: The Motley Fool

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small ...

Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says

on MSN ago, source:

Mizuho Securities initiated coverage on Enliven Therapeutics Inc (NASDAQ:ELVN), a clinical-stage precision oncology company ...

Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event

10h ago, source:

Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 ...

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential

2d ago, source:

Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDANo FDA-approved ...

Sapience Therapeutics Announces Oral Presentation at the Upcoming 2024 ASCO Annual Meeting Featuring ST101 Phase 2 Results in GBM

16h ago, source:

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...

Aptevo Therapeutics Provides Pipeline Update

15d ago, source: Stockhouse

About Aptevo Therapeutics Inc. Aptevo Therapeutics Inc. is a clinical-stage biotechnology ... the availability and timing of data from ongoing clinical trials, the trial design includes combination ...

Design Therapeutics Inc DSGN

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Design Therapeutics Inc DSGN

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Design Therapeutics Inc.

7d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...